Boards


The CBC is supported by a number of academic leaders from Northwestern University, The University of Chicago, and the University of Illinois Chicago (UIC). In addition to Chicago area leadership, our board membership includes a group of interdisciplinary advisors outside of the CBC’s member institutions. The CBC boards meet regularly to discuss CBC initiatives, award and educational programs, and strategies.


Executive Oversight Board

The Executive Oversight Board (EOB) provides general oversight of the CBC, holding the CBC accountable for achieving the goals established for Phase 2. The members of the EOB also provide guidance and, where possible, assistance on the major Phase 2 initiatives to expand linkages with the biomedical industry, fundraise, and elevate the public profile of the CBC. Until recently, the Provosts of each of the CBC universities (Northwestern University (NU), the University of Chicago (UChicago), and the University of Illinois Chicago (UIC)) directly oversaw the CBC and provided institutional responsibility working primarily through the EOB. As of April 20, 2020, following the CBC Governance Committee recommendation, the governance structure of the CBC reports to the CBC universities Chief Scientific Officers (CSOs) who hold the positions of Senior Research Officers at the three CBC universities.

The EOB is composed of representatives from:

  • the Foundation (initially The Searle Family and The Chicago Community Trust),
  • the universities (the three CSOs), and
  • the biomedical industry (the biotechnology, pharmaceutical and/or venture capital sectors; pending).

 
CURRENT MEMBERSHIP:

Angel Gibson
Executive Vice President
Kinship Foundation (The Searle Family)

Joanna Groden, PhD
CBC Chief Scientific Officer for UIC
Vice Chancellor for Research
University of Illinois Chicago

Erin Adams, PhD
CBC Chief Scientific Officer for UChicago
Vice Provost for Research & Senior Research Officer
The University of Chicago

Eric J. Perreault, PhD
CBC Chief Scientific Officer for NU
Vice President for Research
Northwestern University

Other membership pending


Scientific Advisory Board

The Scientific Advisory Board’s (SAB) overarching goal will be to evaluate annually the scientific agenda and programs of the CBC to ensure the highest scientific standards and the stature of the CBC as an intellectual leader in scientific circles are maintained.

 
CURRENT MEMBERSHIP:

Updated: January 1, 2023

Luisa DiPietro, DDS, PhD
CBC Scientific Advisor for UIC
Director, Center for Wound Healing and Tissue Regeneration
Professor of Periodontics
Department of Periodontics
University of Illinois Chicago College of Dentistry

Richard Morimoto, PhD
CBC Scientific Advisor for NU
Bill and Gayle Cook Professor of Biology
Director, Rice Institute for Biomedical Research
Department of Molecular Biosciences
Northwestern University


Accelerator Venture Board


CBC Accelerator Award program proposals are evaluated by the CBC Accelerator Venture Board (AVB), composed of civic minded venture capital professionals, who generously donate their time to assess finalized investment theses and recommend funding for viable Accelerator Award proposals. The AVB will meet regularly throughout the year.


Boards

The CBC is supported by academic leaders from Northwestern University, The University of Chicago, and the University of Illinois Chicago (UIC). In addition to leadership, our board membership includes interdisciplinary advisors outside of the CBC’s member institutions. The CBC boards meet regularly to discuss CBC initiatives, award and educational programs, and strategies.

Executive Oversight Board

Erin J. Adams, PhD
Vice Provost for Research & Senior Research Officer
The University of Chicago
Joanna Groden, PhD
Vice Chancellor for Research
University of Illinois Chicago
Eric J. Perreault, PhD
Vice President for Research
Northwestern University


Accelerator Venture Board

2Flo Ventures Bessemer Venture Partners J&J Innovation Phase Capital
AbbVie Ventures Breakout Ventures KdT Ventures Portal Innovations
Abingworth Cincytech Bio Laerdal Million Lives Fund Qral Group
Agent Capital Deep Work Capital Luma Group Smarthealth Catalyzer
ARCH Venture Partners Deerfield MPM Capital Undettered Capital
Astellas Eli Lilly MRL Ventures Fund Venture Investors
Astra Zeneca Illinois Ventures Orbimed Xeris Pharma
Atlas Ventures Indie Bio PACE Healthcare Capital Xontongeny
Bain Capital Insight Partners Pathway Bioventures Zeal Capital Partners


Ad Hoc Science Board** (triage review)
Jim Audia, PhD
Flare Therapeutics
Michael Bemben, PhD
Janssen r&D
Diana Bolotin, MD, PhD
The University of Chicago
Joanna Burdette, PhD
University of Illinois Chicago
Kunai Desai, MD, MBA
The University of Chicago
Lisa Dhar, PhD
Northwestern University
Steve Elmore, PhD
AbbVie
Amy Heimberger, MD
Northwestern University
Jeff Hubbell, PhD
The University of Chicago
James Kath, PhD
AbbVie
Priya U Kumthekar, MD
Northwestern University
Brian Layden, MD, PhD
University of Illinois Chicago
Svetomir Markovic, MD, PhD
Mayo Clinic
Kay McLeod, PhD
The University of Chicago
Raghu Mirmira, MD, PHD
The University of Chicago
Terry Moore, PhD
University of Illinois Chicago
Satish Nadig, MD, PhD
Northwestern University
Scott Oakes, MD
The University of Chicago
Modestus Obochi, PhD, MBA
Sernova
Evan Scott, PhD
Northwestern University
Jim Summers, PhD
SV Health Investors
Savas Tay, PhD
The University of Chicago
Annabelle Santos Volgman, MD
Rush University Medical Center

**in addition to the ad hoc panel listed here, we engage domain experts during each ad hoc committee meeting, depending on the therapeutic focus of the applications under review.



back to top